News

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, announced a supply agreement with the government of the United Kingdom to supply mRNA-1273, its COVID-19 vaccine...

Moderna, Inc.,a biotechnology company pioneering messenger RNA therapeutics and vaccines to create a new generation of transformative medicines for patients, announced that the EMA human medicines committee (CHMP) has started a rolling review of mRNA-1273, the Company’s vaccine candidate...

The public will be better protected from COVID-19 with £12.2 million of funding awarded to potentially life-saving research into how the virus spreads and evolves through genome sequencing. The COVID-19 Genomics UK (COG-UK) Consortium will use the funding to expand...

Abzena, a global partner research organization for integrated bench to market solutions for biologics and bioconjugates, has announced upgrades of its chemistry GMP suites. The Bristol PA site manufacturing facility upgrades allow Abzena’s ADC client projects to seamlessly progress from...

CPhI & P-MEC China returns as a hybrid event in Shanghai (16-18 December, 2020), with a physical exhibition running alongside Virtual Expo Connect (18 November – 18 December, 2020) for international audiences unable to attend. The physical exhibition will be...

SIRIO – a leading nutraceutical contract development and manufacturing organisation (CDMO) – has completed a new ‘smart factory’ at its Ma’anshan site, with Internet of Things (IoT) enabled automated processes and monitoring, intelligent distribution robotics and Artificial intelligence (AI). Sirio...

Onyx Scientific has announced it is investing in a new facility at its UK site in order to prepare for the approval of a commercial API license. The new facility, which represents a £3m investment, is currently in the design...